ClinicalTrials.gov
public full text
Public Domain
Botulinum Toxin Type A for Neuropathic Pain in Patients With Diabetic Peripheral Polyneuropathy
The purpose of this study is to determine whether botulinum toxin A is effective in the treatment of neuropathic pain in patients with diabetic peripheral polyneuropathy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prevalence, Hallmark-Based Mechanisms, and Risk Factors of Peripheral Diabetic Neuropathy: A Systematic Review and Meta-Analysis.#633118
- Pharmacological treatment for painful and symptomatic diabetic neuropathy - a systematic review and network meta-analysis / Velina Vasileva Shishkova-Stoev ; Gutachter: Sabrina Schlesinger, Brenda Wilhelma Corinna Bongaerts#983186
- A Study to Evaluate the Safety and Effectiveness of Mirogabalin in Chinese Adult Patients With Diabetic Peripheral Neuropathic Pain (DPNP) in Real-world Clinical Practice Setting (ReMIssion Study)#1060439
- A Pilot Study of Needle Size and Pain Perception With Botulinum Toxin A Injections#840725
- Cognitive Behavioral Therapy for Painful Diabetic Neuropathy#160249
Record · ID 839651
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive